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L-T3 and L-T4 activated the Na
/H exchanger of L-6 myoblasts,
with a fast nongenomic mechanism, both in the steady state
and when cells undergo acid loading with ammonium chlo-
ride. Monitored with the intracellular pH-sensitive fluores-
cent probe 2,7-bis(carboxyethyl)-5(6)-carboxyfluorescein,
activation of the exchanger appeared to be initiated at the
plasma membrane, because T3-agarose reproduced the effect
of L-T3, and triiodothyroacetic acid, a hormone analog previ-
ously shown to inhibit membrane actions of thyroid hormone,
blocked the action of L-T3 on the exchanger. We show here for
the first time that transduction of the hormone signal in this
nongenomic response requires tyrosine kinase-dependent
phospholipase C activation and two different signaling path-
ways: 1) mobilization of intracellular calcium, assessed by the
fluorescent probe fura-2, through activation of inositol tris-
phosphate receptors and without contributions from extra-
cellular calcium or ryanodine receptors; and 2) protein phos-
phorylation involving protein kinase C and MAPK (ERK1/2),
as shown by the use of kinase inhibitors and by immunoblot-
ting for activated kinases. (Endocrinology 145: 5694–5703,
2004)
THE NA/H EXCHANGER type 1 (NHE-1) is a ubiq-uitous integral plasma membrane protein that ex-
changes extracellular Na for cytoplasmic H according to
concentration gradients (1–3). It modulates intracellular pH
(pHi) and cell volume. The exchanger does not require en-
ergy for activity but depends indirectly on the Na/K-
ATPase. Activity is also influenced by growth factors, mi-
togens, hormones, integrins, and hyperosmolarity (4–7).
NHE-1 is a phosphoglycoprotein of 815 amino acids that
contains Ca2/calmodulin binding sites and several sites of
phosphorylation (1, 8). Regulation of the exchanger at the
molecular level can occur through at least three different
mechanisms: 1) interaction of a regulatory factor with a crit-
ical cytoplasmic region of NHE-1; 2) direct phosphorylation
of serine, threonine, or tyrosine residues in the cytoplasmic
domain, or 3) Ca2/calmodulin binding (3). Several protein
kinases may be involved in the phosphorylation of NHE-1,
including Ca2/calmodulin-dependent kinase (8), protein
kinase C (PKC) (8, 9), phosphatidyl inositol 3-kinase (9), and
members of the MAPK pathways (2, 10). The rapid activation
of NHE-1 by growth factors and hormones is usually asso-
ciated with phosphorylation of the cytoplasmic domain (1).
After deletion of the cytoplasmic tail with its potential phos-
phorylation sites (amino acids 636–815), however, approx-
imately 50% of the activation achieved upon exposure of cells
to growth factors is preserved, suggesting that other path-
ways are operative for full activation (11).
Nongenomic actions of thyroid hormone have been de-
scribed at the level of the plasma membrane, cytoskeleton,
cytoplasm, and organelles of mammalian cells (12). Some of
these actions rapidly lead to posttranslational modification
of nucleoproteins, e.g. serine phosphorylation of the nuclear
thyroid hormone receptor TR1 (13), estrogen receptor (14),
and p53 (15). These hormone actions on nucleoproteins are
mediated by MAPK (ERK1/2). Upstream of MAPK, PKC and
the phosphatidylinositol pathway may be activated by io-
dothyronines (12–16). These effects of the hormone have
been demonstrated in cells that lack functional nuclear thy-
roid hormone receptors (15, 16). The mechanisms by which
thyroid hormone nongenomically affects the activity of
plasma membrane ion channels and ion pumps (17) are not
well understood and are the focus of the present report.
Activation of MAPK by thyroid hormone (l-T3) and rapid
modulation of plasma membrane ion pumps imply the ex-
istence of discrete membrane receptors for the hormone that
may be linked to signal transduction pathways. Membrane
binding sites for thyroid hormones were identified years ago
in cell membranes from human and rat erythrocytes (18–21)
and rat hepatocytes (22, 23) (for a recent review see Ref. 24).
For l-T3, two stereospecific binding sites were detected in
these membranes; one with apparent dissociation constant
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(Kd) values in the lower nanomolar range, and the other with
Kd in the (sub)micromolar range. Linkage between such
binding sites and hormone actions has not been established.
One of our laboratories has recently shown that the extra-
cellular domain of a structural membrane protein, integrin
V3, is capable of binding thyroid hormone and that such
binding activates MAPK (25). Occlusion of the site prevents
activation of MAPK by iodothyronines and prevents cellular
actions of the hormone downstream of MAPK. Thus, a cell
surface binding site for the hormone has been identified that
is associated with certain nongenomic effects of thyroid
hormone.
Thyroid hormone has both genomic (26–29) and non-
genomic (30, 31) effects on the activity of the Na/H ex-
changer. Evidence that the primum movens in nongenomic
effects of thyroid hormone was an increase in intracellular
calcium was first shown in 1989 by Segal and Ingbar in rat
thymocytes (32). The authors concluded that the increased
calcium could be relevant to the activity of adenylate cyclase,
cAMP concentration, and 2-deoxyglucose uptake. Warnick et
al. (33) later showed that skeletal muscle sarcoplasmic retic-
ulum Ca2-ATPase activity is thyroid hormone responsive.
It has been postulated that the effect of thyroid hormone on
the Ca2-ATPase of sarcoplasmic reticulum may contribute
to the shortened relaxation phase found in patients with
thyrotoxicosis (34).
Physiological concentrations of thyroid hormone increase
pHi through activation of the Na
/H exchanger, both at the
steady state and after an acid load with ammonium chloride,
in cultured L-6 myoblasts from rat skeletal muscle (30). These
results also indicate a physiological role for thyroid hormone
in the recovery processes after muscle contraction and con-
sequent acidosis. Rapid nongenomic effects of thyroid hor-
mone have been reported also in chick embryo hepatocytes
at different stages of embryonic development on two plasma
membrane transport systems: the Na/H exchanger and
the amino acid transport system A (31). Both transport sys-
tems were activated through a transduction pathway involv-
ing PKC, phosphatidyl inositol 3-kinase, and the MAPK
pathway (31).
In the present studies, we have determined whether the
reported nongenomic activation by thyroid hormone of the
Na/H exchanger in L-6 myoblasts is mediated by the same
pathways involved in the transduction of nongenomic ac-
tions of this hormone in other cell types. In particular, we
have examined the potential role of intracellular calcium
levels. Our data indicate that at least two major pathways are
operative in the nongenomic activation of the NHE-1 by
thyroid hormones: intracellular calcium mobilization and
kinase activation. Additionally this work confirms that l-T4
behaves as a prohormone in the l-T3 action on the Na
/H
exchanger in L-6 cells.
Materials and Methods
Cell culture
L-6 cells from rat skeletal muscle were obtained from the American
Type Culture Collection (Rockville, MD). Cells were grown in DMEM
supplemented with 10% fetal bovine serum, 100 g/ml streptomycin, and
100 U/ml penicillin in an atmosphere of 5% CO2 at 37 C and were kept
in culture as myoblasts by continuous passages at preconfluent stages.
Determination of pHi
For the fluorescence assays, cells were grown in chamber slides (Lab-
Tek, Nunc, Naperville, IL) and used at confluency. Before the experi-
ment, cells were rendered quiescent by serum deprivation for 5 h.
Intracellular pH was measured using the pHi indicator 2,7-bis(carboxy-
ethyl)-5(6)-carboxyfluorescein tetra-acetoxymethylester (BCECF/AM).
To rule out the contribution of HCO3
-dependent transport mechanisms
(35), all experiments were carried out in bicarbonate-free buffer with the
following composition (mm): 135 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 10
glucose, 20 HEPES (pH 7.3). This buffer (henceforth called Na buffer)
was used for the incubation with the fluorescent probe and for the
determination of pHi unless otherwise stated; the cells incubated in this
buffer were considered virtually depleted of bicarbonate.
To carry out experiments with an acid load, solutions containing
NH3/NH4
 were prepared from the above buffer with replacement of
20 mm NaCl with 20 mm NH4Cl, and the remaining external Na
 was
routinely replaced by equimolar choline chloride to keep the antiport
quiescent. Incubation with the fluorescent dye was carried out as fol-
lows: cells were washed twice with Na buffer and were thus considered
bicarbonate free. Cells were then incubated in Na buffer with
BCECF/AM at the final concentration of 1 g/ml for 20 min at 37 C in
the dark. Then the medium containing the dye was eliminated, and the
cells were washed twice with the Na buffer.
Routinely at the end of each experiment, calibration of fluorescence
vs. pH was carried out by an established method (36) using the K-H
ionophore nigericin (5 m) added to cells suspended in a K buffer; the
latter had the same composition as the Na buffer but with NaCl re-
placed by equimolar concentrations of KCl. Under these conditions,
intracellular and extracellular pH are equilibrated (pHi  pHo). The
extracellular pH was changed with 10-l aliquots of 1 m 2-[N-morpho-
lino]ethanesulfonic acid or 1 m Tris and measured with a glass electrode
inserted directly into the cuvette. Intracellular fluorescence was deter-
mined and plotted vs. extracellular pH. The calibration curve was linear
over the pH range 6.5–7.8 (data not shown).
Fluorescence was measured under continuous magnetic stirring at a
controlled temperature (37 C) in a PerkinElmer (Norwalk, CT) LS-50B
luminescence spectrometer equipped with a fast filter accessory for the
dual-excitation single-emission ratio technique. Excitation wavelengths
were set at 498 nm (pH-dependent component) and 450 nm (pH-inde-
pendent component) with emission at 530 nm, using 5- and 10-nm slits,
respectively, for the two light paths. This allowed measurements of pHi
that were not dependent on cell concentration and dye loading (37).
Determination of intrinsic i
The total intracellular buffering capacity t is defined as: t 
CO2  i. In the nominally HCO3
-free solutions used in this study,
CO2 was assumed to be negligible and t was therefore taken to be equal
to i. The NH4
 pulse technique was used to determine i, as previously
described (38) according to the following formula: i  [NH4
]i/pHi,
where [NH4
]i represents the change in concentration of intracellular
NH4
 after exposure to or removal of extracellular NH3, and pHi
represents the corresponding change in pHi. The [NH4
]i during
the NH4Cl pulse was calculated as previously reported (38) from the fol-
lowing equation: [NH4
]i  [NH3]i 10
8.92pHi, taking into account that
NH3 equilibrates across the cell membrane (i.e. [NH3]i  [NH3]o) and
that the pKa of NH4
 (8.92) is the same intra- and extracellularly.
[NH4Cl] in the absence of added NH4Cl was assumed to be zero.
From the product of  and the rate of pHi recovery, the net efflux of
acid J can be calculated and expressed as mm/min.
[Ca2]i measurement
Cells were used for the determination of [Ca2]i from 72–96 h after
plating, at 90% confluence. [Ca2]i was determined by measuring the
fluorescence signal from the Ca2 indicator fura-2, as previously re-
ported (39). The cells in one flask ( 6  106 cells) were loaded with
fura-2/AM by incubating them for 30 min in the dark at room temper-
ature in HEPES buffer solution: 20 mm HEPES, 137 mm NaCl, 2.7 mm
KCl, 1 mm MgCl2, 1.5 mm CaCl2, 5.6 mm glucose, and 1 m fura-2/AM.
Fura-2/AM is a membrane-permeant Ca2-insensitive ester of the
Ca2 probe fura-2, which becomes Ca2 sensitive and remains trapped
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intracellularly after hydrolysis by nonspecific intracellular esterases.
After two washes in fura-free HEPES buffer, the cells were scraped and
centrifuged for 5 min at 1000 rpm to remove extracellular fura-2/AM.
Cells were resuspended in 6 ml HEPES buffer and allowed to recover
for 2 h in the same buffer at room temperature to ensure full hydrolysis
of the fura-2 ester. The tubes with cells in suspension were wrapped in
aluminum foil to protect them from light. For measurements, 600 l of
cell suspension ( 6  105 cells) were dispersed into 3 ml of HEPES
buffer.
Fluorescence was recorded at 340- and 380-nm excitation wave-
lengths and 500-nm emission wavelength (10-nm slit width). All deter-
minations were carried out at 37 C, and full mixing was achieved by
magnetic stirring. The fluorescence calibration was initiated by perme-
abilizing the cells to calcium with the ionophore ionomycin (10 m) to
yield the maximum fluorescence, Fmax, followed by displacement of
calcium from its complex with fura-2 by addition of EGTA (3 mm) to
yield Fmin. The concentration of [Ca
2]i was reflected in the ratios of the
fluorescence intensities of fura-2 emission at 500 nm induced by the
alternating excitation wavelengths (340–380 nm) according to the for-
mula (40) [Ca2]i  Kd  [(F –Fmin)/(Fmax –F)]  [(Fmin 380 nm)/(Fmax
380 nm)], where F, Fmin, and Fmax are the fluorescence ratios recorded
during the experiment (F) or during calibration tests (Fmin and Fmax), and
Kd is the fura-2 dissociation constant (150 nm).
Western blot analysis
Subconfluent cells, after hormone treatment, were washed twice in
ice-cold PBS and then harvested with trypsin and homogenized with a
Teflon pestle into ice-cold 10 mm Tris-HCl (pH 7.4) containing 1 mm
CaCl2, 150 mm NaCl, 1 mm phenylmethylsulfonyl fluoride, and 5 g/ml
leupeptin. Particulate fractions were obtained by centrifuging samples
at 100,000  g for 30 min (41). In other experiments, the harvested cells
were sonicated to obtain the total cell lysate (42). Proteins from partic-
ulate and total cell lysate were solubilized in 0.125 m Tris-HCl (pH 6.8)
containing 10% SDS, 1 mm phenylmethylsulfonyl fluoride, and 5 g/ml
leupeptin and boiled for 2 min. Equal amounts (20 g) of membrane and
total proteins were resolved by 7% SDS-PAGE (PKC-) or 10% SDS-
PAGE (ERK and ERK-P) at 100 V for 1 h and then transferred to nitro-
cellulose filters for 45 min at 100 V and 4 C. The nitrocellulose was treated
with 3% BSA in 138 mm NaCl, 26.8 mm KCl, 25 mm Tris-HCl (pH 8.0),
0.05% Tween 20, and 0.1% BSA and then probed at 4 C overnight with
anti-ERK-P or anti-PKC- antibodies (1 g/ml). The nitrocellulose was
stripped by Restore Western blot stripping buffer (Pierce Chemical Co.,
Rockford, IL) for 10 min at room temperature and then probed with
anti-ERK antibody (1 g/ml). Antiactin antibody (1 g/ml) was used
to normalize the sample loading. Bound antibodies were visualized
using enhanced chemiluminescence detection (CDP-Star, NEN Life Sci-
ence Products, Boston, MA). Protein content was quantified by densi-
tometric analysis of Western blots (Fluor-S, Bio-Rad, Hercules, CA).
Solutions
BCECF/AM (1 mg/ml) and 5-(N-ethyl-N-isopropyl)amiloride (EIPA)
(10 mm), genistein, U 73122, H-7, calphostin C, Ro 31-8220, phorbol
12-myristate 13-acetate (PMA), PD 98059, U 0126, geldanamycin, ryan-
odine, and calmidazolium chloride were dissolved in dimethyl sulfox-
ide, which did not affect the fluorescence signal at the employed con-
centrations. Nigericin (10 mm) was dissolved in ethanol. Thyroid
hormones and analogs were dissolved initially as 1 mm stock solutions
in 0.1 m NaOH and then diluted in buffer to the final desired concen-
tration. 6-n-Propyl-2-thiouracil (PTU) (1 mm) and caffeine were aqueous
solutions.
Materials
DMEM, antibiotics, and sterile plastic ware for cell culture were from
Flow Laboratory (Irvine, UK). Fetal bovine serum was from GIBCO
(Grand Island, NY). Fura-2/AM and BCECF/AM were obtained from
Molecular Probes (Eugene, OR). Nigericin, ionomycin, HEPES, 2-[N-
morpholino]ethanesulfonic acid, Tris(hydroxymethyl)aminomethane,
l-T3 (sodium salt), l-T4 (sodium salt), 3,3,5-triiodothyroacetic acid
(triac), rT3, PMA, genistein, H-7, 1,2-bis(2-aminophenoxy)ethane-N,N,
N’,N’-tetraacetic acid tetrakis(acetoxymethylester) (BAPTA/AM),
EGTA, caffeine, ryanodine, calmidazolium chloride, and activated CH-
Sepharose 4B were supplied by Sigma Chemical Co. (St. Louis, MO).
d-T3 (free acid), calphostin C, and PTU were from ICN Pharmaceuticals
(Costa Mesa, CA). l-T3-agarose was prepared as reported in Affinity
Chromatography Handbook, Principles and Methods, at www.amer-
shambiosciences.com. EIPA was obtained from Research Biochemicals
International (Natick, MA). PD 98059, U 0126, and geldanamycin were
from Alexis Biochemicals (Laufelfingen, Switzerland). U 73122 and Ro
31-8220 were obtained from Calbiochem (La Jolla, CA). Monoclonal
anti-PKC-, anti-ERK1/2, anti-ERK1/2-P, and anti--actin antibodies
were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). All
other chemicals were of the purest grade available from Merck (Darm-
stadt, Germany).
Results
Effect of thyroid hormone on pHi
We have previously shown that l-T3 and l-T4 activate the
Na/H antiport in L-6 cells from rat skeletal muscle by a
rapid, nongenomic mechanism (30). Representative experi-
ments demonstrating the rapid nongenomic effects of thy-
roid hormones on the pHi of L-6 cells are shown in Fig. 1. The
effect of l-T3 (1 nm) on the Na
/H exchanger was signif-
icant when the exchanger activity was measured both at the
steady state (Fig. 1A) and under acid load with ammonium
chloride (Fig. 1, B and C). Figure 1A also shows the effects
of T3-agarose (1 nm) and l-T4 (100 nm). When L-6 myoblasts
were maintained in a HEPES-buffered solution containing
equimolar choline chloride (instead of NaCl) to keep the
antiport quiescent and then exposed to NH4Cl, the pHi in-
creased rapidly by an average of 0.20 pH units; this was
because of diffusion of NH3. The pH change was followed by
a slower return toward the baseline. Abrupt removal of
NH4Cl at this point rapidly decreased the pHi 0.3–0.4 U
because NH3 left the cell. The readdition of the Na
 buffer
caused a recovery of pHi; this effect was enhanced when
thyroid hormone was added to the cells at the time of re-
covery, together with the Na buffer (Fig. 1B).
From the regression lines computed from such experi-
ments, it was possible to calculate the rate of recovery in the
pH range 6.8–7.2 (Fig. 1C). The addition of l-T3 at the time
of recovery affected both the rate of recovery and the final
set-point pH reached by the cells. The x-axis intercepts for
control cells, thyroid hormone-treated cells, and thyroid hor-
mone-treated cells plus inhibitor were 7.06, 7.23, and 7.05,
respectively. The pH decrease caused by the removal of
NH4
 was used to evaluate the buffering capacity () when
the acid transport mechanisms are blocked. The addition of
l-T3 did not significantly affect , but the rate of recovery and
the net efflux of acid J (i.e. acid extrusion rate) were signif-
icantly increased (Table 1).
To identify the signal transduction pathways involved in
the activation of the Na/H exchanger by l-T3 in L-6 myo-
blasts, we assessed 1) the ability of thyroid hormones to
change intracellular calcium ion concentration and 2) the
response to thyroid hormone of several signal-transducing
protein kinases.
Effect of thyroid hormone on [Ca2]i
Measurements of [Ca2]i with fura-2 showed an abrupt
transient peak at approximately 100 sec after addition of l-T3
(1 nm) (Fig. 2). Also l-T4 (100 nm) caused an increase in
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[Ca2]i but with a lag time of approximately 6 min (Fig. 2).
The difference in the lag times for l-T3 and l-T4 was similar
to those found in the pH experiments previously reported
(30). The effect of l-T4 on the Ca
2 concentration was blocked
in the presence of the 5-deiodinase inhibitor PTU (30), con-
firming that l-T4 here behaves as a prohormone leading to
l-T3 formation (data not shown). Calcium mobilization in-
creased with increasing hormone concentration, reflecting
the response of the Na/H exchanger, whereas the analogs
d-T4, triac, and rT3, each tested at two selected concentra-
tions, did not show any significant effect (Table 2).
The Ca2 signals had a rather unusual form, being ex-
tremely sharp and short-lived. They were very different in
shape from the increase of pH that was continuous, reaching
a maximum in approximately 20 min. When 10 m phenyl-
ephrine, a well-characterized Ca2 activator, was used, sim-
ilar signal changes in [Ca2]i were obtained (data not shown).
It is possible that the efficient Ca2 sequestering system
present in the muscle cells could explain this behavior, as
found for similar cell types (43). The short lag time indicated
that the calcium response was because of a nongenomic effect
of l-T3, most likely mediated through the activation of a cell
membrane receptor. This was confirmed in experiments us-
ing T3-agarose, a membrane-impermeant l-T3 analog, which
produced changes in the [Ca2]i with exactly the same time
course as l-T3 itself. However, the lag times observed in the
studies of pHi were identical with the ones measured for the
calcium response: approximately 100 sec for l-T3 and T3-
agarose, and approximately 5–6 min for l-T4, at a concen-
tration 100 times higher (30).
An increase in [Ca2]i can be caused by either entrance of
extracellular calcium or release of calcium from intracellular
stores, or both. The experiments shown in Fig. 3 are in agree-
ment with the hypothesis that intracellular Ca2 mobiliza-
tion occurs after the addition of l-T3 to the cells, because the
FIG. 1. Effect of L-T3 on the pHi at the steady state and after acid load with NH4Cl in L-6 myoblasts. A, Steady-state measurement of pHi in
the presence of L-T3 (1 nM), T3-agarose (1 nM) or L-T4 (100 nM). The addition of hormones is indicated by the arrow. The three thyroid hormone
preparations all caused elevation in pHi over 20 min. B, pHi recovery from an acid load carried out with a NH3-NH4
 pulse in a choline chloride
buffer to keep the exchanger quiescent. Cells were exposed to 20 mM NH4Cl for 4 min. During the pulse, the pHi increased (because of entry
of NH3 into the cells) and then decreased toward the baseline because of slower influx of NH4
. The abrupt removal of the choline chloride
medium containing NH4Cl and readdition of the Na
 buffer gave rise to a rapid recovery of pHi. Also shown is the effect of L-T3 (10
–9 M) and
hormone plus PD 98059 (10 M) at the time of recovery. Experiments similar to the one shown were carried out for all inhibitors reported in
Table 1, but are not shown. C, Regression lines for control, L-T3 (1 nM), and L-T3 plus PD 98059, calculated from recovery experiments similar
to those shown in B. The data are the means of four to six experiments.
TABLE 1. Effect of L-T3 (1 nM) and PKC and MAPK pathway
inhibitors on the buffering capacity () and acid extrusion rate (J)
after acid load experiments with ammonium chloride in L-6
myoblasts
Addition  J
None 60  15 16  5
L-T3 80  24 36  10
a
L-T3 and PD 98059 58  13 16  8
L-T3 and U 0126 55  15 15  5
L-T3 and geldanmycin 57  12 16  8
L-T3 and H-7 60  15 16  5
L-T3 and calphostin C 55  12 18  8
L-T3 and Ro 31-8220 50  15 16  7
The buffering capacity () is reported as mM/pH, whereas the net
efflux acid (J), is reported as mM/min. Values are the mean  SD of
three to five different experiments. The values are calculated at pH
6.8. Hormone was given at the time of recovery, whereas the inhib-
itors, except calphostin C, were given before the acid load as reported
in Fig. 1 and in Materials and Methods. For calphostin C treatment
of cells, see Fig. 5.
a P  0.05 at least, with respect to control.
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use of Ca2-free extracellular buffer or the presence of EGTA
in the extracellular buffer (data not shown) did not alter the
response of l-T3. In contrast, BAPTA, a selective chelator of
intracellular Ca2 stores (44), and U 73122, an aminosteroid
phospholipase C (PLC) inhibitor (45), significantly inhibited
the activation by l-T3 (Fig. 3). Triac was minimally effective
by itself (Table 2) but when given together with l-T3 strongly
inhibited the hormone effect on [Ca2]i (Fig. 3). Calmidazo-
lium chloride (calmi, 1 m), an inhibitor of calmodulin, com-
pletely prevented the increase in [Ca2]i caused by the hor-
mone (Fig. 3).
To characterize further the effect of thyroid hormone on
the [Ca2]i, we used caffeine and ryanodine to assess the
possible involvement of ryanodine receptors (46, 47). Both
caffeine (5 mm) and ryanodine (100 nm) gave rise to an
increase of [Ca2]i approximately 30 sec after drug addition
(Fig. 4, A and C). When thyroid hormone was given together
with either caffeine or ryanodine, the characteristic calcium
spike caused by l-T3 was observed superimposed on the
increase caused by either activator (Fig. 4, B and D). These
results suggest that the nongenomic effect of l-T3 was inde-
pendent of ryanodine receptor activation. The effects of ry-
anodine and caffeine were evident also in the presence of the
inhibitor U 73122 or in a Ca2-free buffer or with the calcium
chelator EGTA in the extracellular medium (data not shown).
FIG. 2. Effect of thyroid hormones L-T3, T3-agarose, and L-T4 on the
[Ca2]i in L-6 myoblasts, measured with the fluorescent probe fura-2.
L-T3 and T3-agarose (1 nM) and L-T4 (100 nM) were added to cell
suspensions (shown by the arrow) as described in Materials and
Methods. Typical curves are shown, representative of at least five to
10 experiments giving very similar traces. The response to L-T4 was
slower than that seen with L-T3, as indicated by the different time
scales; the time scale for L-T3 and T3-agarose is the same.
TABLE 2. Effect of thyroid hormones and analogs on the
intracellular calcium mobilization in L-6 myoblasts
Hormone/analog 1 nM 100 nM
None 70  20 70  20
L-T3 315  50 450  70
a
L-T4 180  45 260  40
b
D-T4 75  15 92  30
rT3 90  20 104  27
Triac 65  15 105  25
Results are given as nM Ca2, reported as the maximum value of
the transient peak, and are the mean  SD of at least three different
experiments.
a P  0.001, derived from a Student’s t test with respect to L-T3,
1 nM.
b P  0.005 with respect to L-T4, 1 nM.
FIG. 3. Effect of different inhibitors, analogs, and chelators on the
mobilization of calcium from intracellular stores in L-6 myoblasts.
The concentrations used were 1 nM L-T3, 0.1 M U 73122, 25 M
BAPTA/AM, 1 M calmidazolium chloride (calmi), and 1 M triac. The
inhibitors were added to the cells 5 min before hormone addition and
did not affect the fluorescent signal. BAPTA/AM, a hydrophobic form
of BAPTA that enters the cells and becomes deesterified to BAPTA
within, was given to the cells for 30 min. BAPTA alone is not shown
for the sake of simplicity, but it did not affect intracellular calcium
mobilization. The label drug stands for L-T3 plus drug or L-T3 plus
buffer without calcium. Results are reported as concentration of in-
tracellular calcium (nM) and are the mean  SD of three to 10 different
experiments.
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Role of kinases and ion transport inhibitors
The effect of l-T3 on pHi was completely blocked by the
specific antiporter inhibitor EIPA (10 m; Fig. 5A). The hor-
mone was not significantly affected by 4,4-diisothiocyana-
tostilbene-2,2-disulfonic acid (0.1 mm), an inhibitor of the
Na-dependent HCO3
 transport, indicating that the con-
tribution of this transport system to the increase of pHi was
negligible. Figure 5A also shows that genistein, an inhibitor
of tyrosine kinases, almost completely prevented the pH
increase caused by hormone. Triac produced a small stim-
ulating effect by itself but when added with l-T3 completely
prevented hormone action (Fig. 5A), analogous to the results
of Ca2 experiments with l-T3 and triac shown in Fig. 3.
We assessed the involvement of two major protein kinase
systems, the PKC and MAPK pathways, in the transduction
of the nongenomic l-T3 signal into an effect on pHi. The PKC
inhibitors H-7, calphostin C, Ro 31-8220, and PMA (depletion
of PKC activity after overnight incubation) as well as the
MAPK pathway inhibitors PD 98059, U 0126, and geldana-
mycin (48) all prevented the activation of the Na/H ex-
changer by l-T3, both in the steady state and under acid
loading (Fig. 1, B and C; Fig. 5B; and Table 1). Figure 1B
shows results of an acid load experiment with ammonium
chloride, carried out in the presence or absence of l-T3, with
or without PD 98059, which indicate that the hormone effect
is significantly reduced in the presence of the MAPK acti-
vation inhibitor. Other common inhibitors of the PKC and
MAPK pathways were used in acid load experiments, and
their effects on the buffering capacity () and acid extrusion
rate (J) are reported in Table 1. These results suggest a com-
plex transduction mechanism involving both PKC and the
MAPK pathway. None of the inhibitors, when applied alone
in the absence of hormone, affected the buffering capacity ()
or the net proton efflux (J). In fact, both parameters depend
on the activation of the pHi sensor, which is not affected by
kinase inhibitors (6). Results of inhibitor studies similar to
those shown in Fig. 1, B and C, and Table 1 were obtained
with l-T4 (10
–7 m), using preincubation times longer than 10
min (data not shown).
The effects of l-T3 on the translocation of PKC- from the
cytosol to the plasma membrane and on activation (phos-
phorylation) of MAPK (ERK1/2) are shown in Fig. 6. Phys-
iological concentrations of l-T3 stimulated both PKC trans-
location and ERK1/2 phosphorylation (Fig. 6, A and C), but
these effects disappeared at higher hormone concentrations,
in contrast to results obtained in the studies of intracellular
calcium mobilization (Table 2). U 73122 inhibited the trans-
location of PKC- induced by thyroid hormone, consistent
with the inhibition of receptor-induced PLC activation at the
cell surface (Fig. 6B). The translocation of PKC was com-
pletely inhibited by Ro 31-8220 and by genistein, whereas the
specific inhibitor of ERK activation PD 98059 did not affect
PKC translocation (Fig. 7A). With regard to the MAPK path-
way, we found that the hormone effect on ERK1/2 activation
was completely inhibited by genistein, PD 98059 and Ro
31-8220 (Fig. 7B). Thus, activation of the MAPK pathway by
thyroid hormone is downstream of activation of PKC.
FIG. 4. Effect of caffeine and ryanodine
on intracellular calcium mobilization in
the presence and absence of thyroid hor-
mone in L-6 myoblasts. Caffeine (5 mM)
and ryanodine (100 nM) were assayed
alone (A and C) or together with 1 nM
L-T3 (B and D). The arrow indicates the
addition of either caffeine/ryanodine
alone or together with the hormone. The
traces reported are representative of at
least five different experiments and
show a hormone-induced sharp tran-
sient increase in [Ca2]i in the presence
of both agents.
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Discussion
Our results show that the fast nongenomic activation by
l-T3 of the Na
/H exchanger in rat skeletal muscle L-6 cells
is mediated in part by an increase in [Ca2]i that is inde-
pendent of a contribution from extracellular calcium. The lag
time for the initiation of the response is approximately 100
sec for the effects of hormone on both pHi and [Ca
2]i, but
the time course of the two events is different. The slow
increase in pHi reaches a plateau in approximately 20 min,
but there is a spike-type response in calcium. The responses
to l-T4 showed a lag time in onset of 7–10 min, apparently
reflecting (PTU inhibitable) deiodination of l-T4 to l-T3 for
responses both in pHi and Ca
2.
The nongenomic effect of l-T3 on pHi is hormone specific.
rT3, triac, and d-T4 had negligible effects, individually, on
pHi (30) and on cytoplasmic calcium concentration. Triac
added with l-T3 to L-6 cells, however, inhibited the effects of
l-T3. This result is not surprising, because one of our labo-
ratories has reported that deaminated T4 (tetrac) can block
nongenomic actions of l-T4 in cells devoid of functional
nuclear thyroid hormone receptor (16) as well as in cells that
contain TR1 (14). We attribute such effects of triac and tetrac
to the ability of these deaminated thyroid hormone analogs
to compete with thyroid hormone for cell surface hormone-
binding sites (13, 16, 49). Although plasma membrane bind-
ing sites for iodothyronines have been described in the past
for human and rat erythrocytes (18–21) and rat hepatocytes
(22–24), it has not been clear that these sites are linked to
intracellular events and thus function as receptors. One of
our laboratories has recently shown that human integrin
V3 binds thyroid hormone dissociably and that tetrac
inhibits association of l-T4 with this integrin (25). This inte-
grin is a structural plasma membrane protein that is linked
to the MAPK signal transduction pathway. Occlusion of the
receptor site on the integrin prevents thyroid hormone from
activating MAPK and has been shown to inhibit cellular
responses to thyroid hormone that are downstream of
MAPK. We have proposed that integrin V3 is the cell
surface receptor primarily involved in thyroid hormone’s
activation of MAPK.
The Na/H exchanger can be activated by several mech-
anisms: interaction of a regulatory factor with a critical cy-
toplasmic region of NHE-1, phosphorylation at different res-
idues on the cytoplasmic domain, and binding by NHE-1 of
the Ca2/calmodulin complex. A high-affinity calmodulin-
binding domain regulates NHE-1 activity in response to
Ca2-dependent signaling mechanisms. At rest, this site may
function as an autoinhibitory domain and inhibit ion trans-
port, but upon activation NHE-1 undergoes a conformational
change that suppresses the autoinhibitory effect and allows
the Ca2-dependent binding of calmodulin. In the current
paper, we show for the first time that the nongenomic effect
of thyroid hormone on the Na/H exchanger in L-6 myo-
blasts is mediated by intracellular calcium mobilization. No
contribution from extracellular calcium is involved, as
shown by the experiments with extracellular and intracel-
lular calcium chelators (EGTA and BAPTA, respectively).
BAPTA by itself had no effect on pHi, but BAPTA plus l-T3
showed a significant inhibition with respect to hormone
alone even though BAPTA did not completely prevent the
increase of pHi, suggesting that other mechanisms that are
not dependent on Ca2 contribute to the activation of NHE-1
(i.e. phosphorylation by kinases).
We examined two families of calcium channels as possible
intracellular sources of the rise in [Ca2]i obtained with thy-
roid hormone: inositol trisphosphate (IP3) receptors and ry-
anodine receptors (RyRs) (46, 47). The IP3 receptor is mod-
ulated by the second messenger IP3 in response to different
activators, such as hormones and growth factors, whereas
the RyRs are calcium channels that control intracellular cal-
cium levels by releasing calcium from the sarco/endoplas-
mic reticulum, an intracellular calcium storage compart-
FIG. 5. Effect of the analog triac, inhibitors of transport systems, and
inhibitors of tyrosine kinase, PKC, and ERK1/2 activation on the
increase of pHi by L-T3 at the steady state in L-6 myoblasts. The
concentrations of these compounds were 10 M EIPA, 0.1 mM 4,4-
diisothiocyanatostilbene-2,2-disulfonic acid, 10–7 M triac, 25 M
BAPTA, 10–7 M genistein (geni), 70 nM U 0126, and 10–4 M H-7.
Concentrations of U 73122 and light-activated calphostin C (calph)
were 1 M, and Ro 31-8220 (Ro 31) and PD 98059 concentrations were
10 M. All inhibitors, except calphostin C and PMA, were applied to
the cells 5 min before hormone addition. The samples containing
calphostin C were light activated with 30 min of dark and 30 min of
light before hormone treatment. The samples assayed for down-
regulation of PKC with PMA (1 M) were incubated overnight. The
label drug stands for L-T3 plus drug. Results are reported as 	pHi/20
min over basal value and are mean  SD of at least three different
experiments.
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ment. The RyR channel can be opened by nanomolar
concentrations of ryanodine, a plant alkaloid, and by milli-
molar caffeine. Our data show that l-T3 and caffeine/ryan-
odine mobilize different pools of intracellular calcium, be-
cause the increase in [Ca2]i caused by these activators
appears quite different in terms of both shape and time
course. The increase caused by opening of RyRs appears after
15–30 sec, whereas the increase caused by l-T3 appears after
approximately 100 sec, probably because of the time required
for the activation of PLC and for membrane phosphoinosi-
tide hydrolysis. Moreover, the increase caused by caffeine/
ryanodine lasts much longer. When the hormone is given to
cells together with nanomolar ryanodine or caffeine in the
millimolar range, the discrete contributions of the two com-
pounds are preserved, indicating that thyroid hormone does
not interact with RyRs but only with IP3 receptors (Fig. 4).
Phosphorylation also contributes to activation of the ex-
changer in response to thyroid hormone. This is supported
by two lines of evidence: 1) a pharmacological approach that
depended upon the effects of inhibitors of PKC and MAPK
FIG. 6. Effect of L-T3 on PKC- transloca-
tion and on phosphorylation and content of
ERK1/2 and effects of signal transduction
inhibitors in L-6 myoblasts. A, Effect of L-T3,
0.1–100 nM, on translocation of PKC- from
cytosol to the plasma membrane. Mem-
brane-associated PKC- was significantly
increased with L-T3, 1 nM for 15 min,
whereas total cellular PKC- was un-
changed. Immunoblots of -actin in this and
subsequent figures indicate equal sample
loading. The graph on the right summarizes
results of densitometric scanning of immu-
noblots, as mean  SD of three to10 similar
experiments. B, Effect of the PLC inhibitor
U 73122 (1 M) on the translocation of PKC
from cytosol to plasma membrane after
treatment with L-T3 (1 nM). C, Effect of L-T3
on the content of total ERK1/2 and phos-
phorylated ERK1/2 (ERK1/2-P) determined
by immunoblot. Cells were treated with L-T3
(1 nM) for 15 min. A maximal amount of
ERK1/2-P was evident with 1 nM L-T3,
whereas total ERK1/2 did not change. P 
0.001 as calculated by the Student’s t test,
with respect to unstimulated (*) or L-T3-
stimulated (°) samples.
FIG. 7. Effect of selected inhibitors of PKC and
the MAPK pathway on translocation of PKC-
to the plasma membrane and the phosphoryla-
tion of ERK1/2. The concentrations of inhibitors
were the same as reported in Fig. 5. A, Western
blots of total and plasma membrane PKC- af-
ter treatment of L-6 cells with L-T3 (1 nM) and
the effect of the inhibitors genistein (G, 0.1 M),
PD 98059 (PD, 10 M), and Ro 31-8220 (Ro, 10
M) on the hormone effect. The graph on the
right corresponds to results of densitometric
scanning of immunoblots; the data represent
the mean  SD of three different experiments. B,
Parallel studies of ERK1/2 phosphorylation in
L-6 myoblasts treated with L-T3 as in A. The
graph on the right corresponds to results of den-
sitometric scanning of immunoblots; the data
represent the mean  SD of three different ex-
periments. The -actin was used to verify the
iso-loading of the samples. P  0.001 as calcu-
lated by the Student’s t test, with respect to
unstimulated (*) or L-T3-stimulated (°) samples.
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pathways on thyroid hormone-induced pHi increase and
2) immunoblotting experiments that showed in thyroid
hormone-treated cells both the translocation of PKC- from
cytosol to the plasma membrane and the phosphorylation of
MAPK (ERK1/ERK2). The involvement of PKC and MAPK
in other nongenomic effects of thyroid hormone in different
cell types has previously been reported (13, 16). Similar roles
of PKC and MAPK in the activation of the Na/H ex-
changer in freshly isolated chick embryo hepatocytes suggest
that common signal-transducing kinase mechanisms might
be operative for the nongenomic effects of thyroid hormone
on this transport system in different cells (31, 49, 50). On the
other hand, studies in one of our laboratories have shown that
a nongenomic effect of estrogen on the Na/H exchanger in
rat aortic smooth muscle cells is mediated by the same PKC and
MAPK pathway (51), and a nongenomic effect of aldosterone
on the Na/H exchanger in MDCK cells mediated by the
MAPK pathway has also been reported (52). It is possible that
other hormones acting through the phosphoinositide and
MAPK pathways may also influence the activity of the
Na/H exchanger via this kinase-dependent mechanism.
A schematic outline of the sequence of events initiated by
thyroid hormones that culminate in modulation of the ex-
changer is shown in Fig. 8. The cell surface hormone signal
is transduced through stimulation of tyrosine kinase activity
and consequent activation of PLC; hydrolysis of phosphatidyl-
inositol bisphosphate by PLC yields IP3 and diacylglycerol
(DAG). The DAG activates the classic isoforms of PKC, whereas
IP3 causes an increase in [Ca
2]i from calcium stores in sarco/
endoplasmic reticulum. The rise in [Ca2]i also supports PKC
activation and its role upstream in the MAPK pathway (16).
Elevation in [Ca2]i appears to be important for activation
of the Na/H exchanger. Regulation of the exchanger de-
pends in several cell types on pathways activated by cellular
acidification (38). Our results indicate that the cytoplasmic
alkalinization caused by thyroid hormone is due to a calci-
um-dependent pathway. The finding described here is new,
in that this effect is activated not by a growth factor or a
peptide hormone, as is usually the case (53), but by thyroid
hormone, a factor thought primarily to act through a nuclear
hormone receptor. L-6 myoblasts from rat skeletal muscle
possess classical nuclear receptors for thyroid hormones (54).
The effect of these hormones on the expression of the
Na/H exchanger units in renal brush border membranes
of mammalian kidney cells in culture and on the expression
of different isoforms of the exchanger in the renal tubule has
been reported (26–29).
We show here a nongenomic cell membrane-initiated ef-
fect of iodothyronines. What is the physiological relevance of
such an effect of l-T3 on L-6 myoblasts from rat skeletal
muscle? A nongenomic effect of thyroid hormone on the
Na/H exchanger could contribute to the appropriate func-
tioning of skeletal muscle myofibrils, because an increase in
basal activity of the exchange, provided by constant ambient
thyroid hormone levels, would support recovery from the ac-
idosis that the muscle develops after the contraction process.
Our results with caffeine and ryanodine suggest that the main
function of this action of thyroid hormone does not involve the
excitation-contraction process, where the RyRs together with
the voltage-sensitive receptors are major actors that do not
appear to respond to thyroid hormone (results not shown).
In a recent review, we have extended the possible phys-
iological functions of a short-term modulation of the ex-
changer by thyroid hormone (50) to different cellular activ-
ities: exocytosis, enzyme activity, and differentiation. It has
been proposed that IP3 receptor-mediated calcium release plays
an important role in different pathways leading either to cell
proliferation or cell death (55). In L-6 myoblasts, both events
may happen, leading to differentiation from myoblasts to myo-
tubes, a process normally associated with certain events of
apoptosis (Incerpi, S., unpublished results). The modulation of
pHi could contribute to discrimination between differentiation
or death response, because it is well known, even if not as a
general rule, that an increase in pHi may be a differentiation
signal, whereas acidification may be a signal for apoptosis (55).
We also propose that the acute nongenomic effects of thyroid
hormone that we can see in the experimental models are very
likely chronic effects that help to set basal activities of homeo-
static pumps and channels in the plasma membrane. This ap-
pears particularly relevant, taking into account that alterations
in thyroid hormone levels have a dramatic impact not only on
the skeletal muscle but also on the myocardium, with conse-
quent alterations of myocardial contractility, speed of relax-
ation, cardiac output, and heart rate (34, 56).
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